Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Effect of macrophage migration inhibitory factor (MIF) in human placental explants infected with Toxoplasma gondii depends on gestational age.

de Oliveira Gomes A, de Oliveira Silva DA, Silva NM, de Freitas Barbosa B, Franco PS, Angeloni MB, Fermino ML, Roque-Barreira MC, Bechi N, Paulesu LR, Dos Santos MC, Mineo JR, Ferro EA.

Am J Pathol. 2011 Jun;178(6):2792-801. doi: 10.1016/j.ajpath.2011.02.005.

2.

Macrophage migration inhibitory factor is up-regulated in human first-trimester placenta stimulated by soluble antigen of Toxoplasma gondii, resulting in increased monocyte adhesion on villous explants.

Ferro EA, Mineo JR, Ietta F, Bechi N, Romagnoli R, Silva DA, Sorda G, Bevilacqua E, Paulesu LR.

Am J Pathol. 2008 Jan;172(1):50-8. doi: 10.2353/ajpath.2008.070432. Epub 2007 Dec 28.

3.

[Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia].

Xie XF, Zhan Y, Ye YH, Li C, Zhang Y.

Zhonghua Fu Chan Ke Za Zhi. 2010 Apr;45(4):278-82. Chinese.

PMID:
20646540
4.

MIF participates in Toxoplasma gondii-induced pathology following oral infection.

Cavalcanti MG, Mesquita JS, Madi K, Feijó DF, Assunção-Miranda I, Souza HS, Bozza MT.

PLoS One. 2011;6(9):e25259. doi: 10.1371/journal.pone.0025259. Epub 2011 Sep 22.

5.

Toxoplasma gondii: impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection.

Terrazas CA, Juarez I, Terrazas LI, Saavedra R, Calleja EA, Rodriguez-Sosa M.

Exp Parasitol. 2010 Nov;126(3):348-58. doi: 10.1016/j.exppara.2010.03.009. Epub 2010 Mar 21.

PMID:
20331989
6.

Susceptibility to Toxoplasma gondii proliferation in BeWo human trophoblast cells is dose-dependent of macrophage migration inhibitory factor (MIF), via ERK1/2 phosphorylation and prostaglandin E2 production.

Barbosa BF, Paulesu L, Ietta F, Bechi N, Romagnoli R, Gomes AO, Favoreto-Junior S, Silva DA, Mineo JR, Mineo TW, Ferro EA.

Placenta. 2014 Mar;35(3):152-62. doi: 10.1016/j.placenta.2013.12.013. Epub 2014 Jan 8.

PMID:
24433846
7.

Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.

Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, Kawakami Y, Toda M.

J Cell Sci. 2012 Jul 1;125(Pt 13):3210-20. doi: 10.1242/jcs.102210. Epub 2012 Mar 27.

8.

17{beta}-Estradiol modulates the macrophage migration inhibitory factor secretory pathway by regulating ABCA1 expression in human first-trimester placenta.

Ietta F, Bechi N, Romagnoli R, Bhattacharjee J, Realacci M, Di Vito M, Ferretti C, Paulesu L.

Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E411-8. doi: 10.1152/ajpendo.00522.2009.

PMID:
20173014
9.

Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta.

Faria MR, Hoshida MS, Ferro EA, Ietta F, Paulesu L, Bevilacqua E.

Reprod Biol Endocrinol. 2010 Aug 4;8:95. doi: 10.1186/1477-7827-8-95.

10.

Oxygen regulation of macrophage migration inhibitory factor in human placenta.

Ietta F, Wu Y, Romagnoli R, Soleymanlou N, Orsini B, Zamudio S, Paulesu L, Caniggia I.

Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E272-80. Epub 2006 Aug 29.

PMID:
16940473
11.

Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.

Xiong C, Huang B, Cun Y, Aghdasi BG, Zhou Y.

Clin Orthop Relat Res. 2014 Jun;472(6):1943-54. doi: 10.1007/s11999-014-3508-y. Epub 2014 Feb 26.

12.

Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex.

Gore Y, Starlets D, Maharshak N, Becker-Herman S, Kaneyuki U, Leng L, Bucala R, Shachar I.

J Biol Chem. 2008 Feb 1;283(5):2784-92. Epub 2007 Dec 4.

13.

MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.

Ruiz-Rosado Jde D, Olguín JE, Juárez-Avelar I, Saavedra R, Terrazas LI, Robledo-Avila FH, Vazquez-Mendoza A, Fernández J, Satoskar AR, Partida-Sánchez S, Rodriguez-Sosa M.

Mediators Inflamm. 2016;2016:9101762. doi: 10.1155/2016/9101762. Epub 2016 Feb 29.

14.

CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.

Zheng YX, Yang M, Rong TT, Yuan XL, Ma YH, Wang ZH, Shen LS, Cui L.

World J Gastroenterol. 2012 May 14;18(18):2253-61. doi: 10.3748/wjg.v18.i18.2253.

15.

Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy.

da Silva RJ, Gomes AO, Franco PS, Pereira AS, Milian ICB, Ribeiro M, Fiorenzani P, Dos Santos MC, Mineo JR, da Silva NM, Ferro EAV, de Freitas Barbosa B.

Front Cell Infect Microbiol. 2017 Jul 26;7:340. doi: 10.3389/fcimb.2017.00340. eCollection 2017.

16.

Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.

Franco PS, Gomes AO, Barbosa BF, Angeloni MB, Silva NM, Teixeira-Carvalho A, Martins-Filho OA, Silva DA, Mineo JR, Ferro EA.

Placenta. 2011 Nov;32(11):838-44. doi: 10.1016/j.placenta.2011.08.012. Epub 2011 Sep 9.

17.

Differential apoptosis in BeWo cells after infection with highly (RH) or moderately (ME49) virulent strains of Toxoplasma gondii is related to the cytokine profile secreted, the death receptor Fas expression and phosphorylated ERK1/2 expression.

Angeloni MB, Guirelli PM, Franco PS, Barbosa BF, Gomes AO, Castro AS, Silva NM, Martins-Filho OA, Mineo TW, Silva DA, Mineo JR, Ferro EA.

Placenta. 2013 Nov;34(11):973-82. doi: 10.1016/j.placenta.2013.09.005. Epub 2013 Sep 18.

PMID:
24074900
18.

Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction.

Wang J, Tong C, Yan X, Yeung E, Gandavadi S, Hare AA, Du X, Chen Y, Xiong H, Ma C, Leng L, Young LH, Jorgensen WL, Li J, Bucala R.

Circulation. 2013 Jul 16;128(3):225-36. doi: 10.1161/CIRCULATIONAHA.112.000862. Epub 2013 Jun 10.

19.

Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.

Xia W, Zhang F, Xie C, Jiang M, Hou M.

Stem Cell Res Ther. 2015 Apr 22;6:82. doi: 10.1186/s13287-015-0076-3.

20.

Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii.

Flores M, Saavedra R, Bautista R, Viedma R, Tenorio EP, Leng L, Sánchez Y, Juárez I, Satoskar AA, Shenoy AS, Terrazas LI, Bucala R, Barbi J, Satoskar AR, Rodriguez-Sosa M.

FASEB J. 2008 Oct;22(10):3661-71. doi: 10.1096/fj.08-111666. Epub 2008 Jul 7.

Supplemental Content

Support Center